Lupus: Clinical Trials

9 trials for Lupus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting. 9 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 6, Recruiting 3
Phase 12Recruiting 2

Follow Lupus: new trials by email Literature Review of Lupus trials Research Report on Lupus

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Mosunetuzumab - Lupus, Systemic Lupus Erythematosus
Phase 2RecruitingHoffmann-La Roche302026-05-252026-10-19
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
CART19 - SLE, Systemic Lupus Erythematosus (SLE)
Phase 1 / Phase 2RecruitingChildren's Hospital of Philadelphia242025-05-062026-09-24
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Tafasitamab, Fludarabine phosphate, Cyclophosphamide - Autoimmune Disorders, Systemic Sclerosis
Phase 1 / Phase 2RecruitingM.D. Anderson Cancer Center472024-07-312026-11-03
JBT-101 in Systemic Lupus Erythematosus (SLE)
JBT-101, Placebo - Systemic Lupus Erythematosus, SLE
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1092017-12-212026-05-06
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
BMS-931699, Placebo matching BMS-931699 - Lupus
Phase 2CompletedBristol-Myers Squibb7302014-11-132019-10-07
Vitamin D3 in Systemic Lupus Erythematosus
Vitamin D3, Vitamin D3 placebo - Systemic Lupus Erythematosus, SLE
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)572008-11-012017-04-26
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
MEDI-545, Placebo - Lupus Erythematosus, Systemic, Lupus
Phase 2CompletedMedImmune LLC872008-07-012016-08-09
Improving Quality of Life for African American Female Adolescents With Lupus
Coping skills and cognitive restructuring techniques, Educational training - Lupus
Phase 2CompletedMedical University of South Carolina1202004-04-012018-05-09
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
pravastatin, aspirin, ramipril - Systemic Lupus Erythematosus, Lupus
Phase 2CompletedBrigham and Women's Hospital1502003-03-012013-12-24

Narrower conditions

Lupus Erythematosus, Systemic (7)  ·  Lupus Nephritis (3)  ·  Autoimmune Diseases (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Graft vs Host Disease (1)  ·  Musculoskeletal Diseases (1)  ·  Scleroderma, Systemic (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Connective Tissue Diseases (7)  ·  Immune System Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Autoimmune Diseases (6)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Glomerulonephritis (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Nephritis (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Avitaminosis (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)

Interventions

Aspirin (1)  ·  CTL019 chimeric antigen receptor (1)  ·  Cholecalciferol (1)  ·  Coping Skills (1)  ·  Cyclophosphamide (1)  ·  Folic Acid (1)  ·  Pravastatin (1)  ·  Ramipril (1)  ·  Training Support (1)  ·  Vitamin B 12 (1)  ·  anabasum (1)  ·  fludarabine phosphate (1)  ·  lenabasum (1)  ·  lulizumab pegol (1)  ·  sifalimumab (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  Children's Hospital of Philadelphia (1)  ·  Hoffmann-La Roche (1)  ·  M.D. Anderson Cancer Center (1)  ·  MedImmune LLC (1)  ·  Medical University of South Carolina (1)

Countries

United States (8)  ·  Argentina (2)  ·  Brazil (2)  ·  Colombia (2)  ·  Italy (2)  ·  Mexico (2)  ·  South Africa (2)  ·  Canada (1)  ·  Chile (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Netherlands (1)

Top investigators

Caitlin Elgarten, MD (1)  ·  Chitra Hosing, MD (1)  ·  Cynthia Aranow, MD (1)  ·  Diane Kamen, MD (1)  ·  Matthew H. Liang, MD, MPH (1)  ·  Meggan Mackay, M.D., M.S. (1)  ·  Robert B. Zurier, M.D. (1)  ·  Ronald T. Brown, PhD (1)  ·  Warren Greth, M.D. (1)

Results publications

PMID 16208639, PMID 21798883, PMID 25777546, PMID 33687069, PMID 42309556

NIH funding

2014 (1), P60AR047782 (1), P60AR049459 (1), UM1AI110494 (1)